Creo Medical Group Plc (CREO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 4,000 | 30,800 | 27,169 | 25,161 | 9,429 |
| Cost of Goods | 2,100 | 15,500 | 14,047 | 13,576 | 5,394 |
| Gross Profit | 1,900 | 15,300 | 13,122 | 11,585 | 4,035 |
| Operating Expenses | 30,700 | 40,100 | 43,878 | 41,492 | 27,072 |
| Operating Income | -28,800 | -24,800 | -30,756 | -29,907 | -23,037 |
| Interest Expense | 400 | 400 | 287 | 363 | 173 |
| Other Income | 200 | 700 | 66 | -69 | -252 |
| Pre-tax Income | -29,000 | -24,500 | -30,977 | -30,339 | -23,462 |
| Income Tax | -1,200 | -2,800 | -4,041 | -5,744 | -3,146 |
| Net Income Continuous | -27,800 | -21,700 | -26,936 | -24,595 | -20,316 |
| Net Income Discontinuous | -900 | N/A | N/A | N/A | N/A |
| Net Income | $-28,700 | $-21,700 | $-26,936 | $-24,595 | $-20,316 |
| EPS Basic Total Ops | -0.08 | -0.07 | -0.14 | -0.14 | -0.13 |
| EPS Basic Continuous Ops | -0.08 | -0.07 | -0.14 | -0.14 | -0.13 |
| EPS Diluted Total Ops | -0.08 | -0.07 | -0.14 | -0.14 | -0.13 |
| EPS Diluted Continuous Ops | -0.08 | -0.07 | -0.14 | -0.14 | -0.13 |
| EBITDA(a) | $-26,100 | $-20,700 | $-27,578 | $-27,414 | $-21,693 |